Postdoctoral Training Fellow in Immunology

The Francis Crick Institute

Fixed-term (4 years).


The Postdoctoral Scientist will carry out research on the immunological impact of endogenous retroviruses in the development and progression of cancer. The focus is on the detection of naturally elicited adaptive immune responses to endogenous retroviral antigens in cancer patients.


This role will be pivotal in ensuring continuation of research on immunity to exogenous and endogenous retroviruses and cancer in the Kassiotis lab. The post holder will be part of a team of researchers in the Kassiotis lab at the Francis Crick Institute and is expected to work within a team that carries out research on immune reactivity to retroviral antigens in the context of infection and cancer.

He/she will be responsible for designing, performing, analysing, and interpreting experiments to investigate the induction and regulation of adaptive immunity to endogenous retroviral antigens, with particular emphasis on T cell responses.

Lab web page:

The Francis Crick Institute is a biomedical discovery institute dedicated to understanding the fundamental biology underlying health and disease. Its work is helping to understand why disease develops and to translate discoveries into new ways to prevent, diagnose, and treat illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases.

An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London, and King’s College London.

The Crick was formed in 2015, and in 2016 it moved into a brand new state-of-the-art building in central London which brings together 1,500 scientists and support staff working collaboratively across disciplines, making it the biggest biomedical research facility under a single roof in Europe.

The Francis Crick Institute will be world-class with a strong national role. Its distinctive vision for excellence includes commitments to collaboration; to developing emerging talent and exporting it the rest of the UK; to public engagement; and to helping turn discoveries into treatments as quickly as possible to improve lives and strengthen the economy.

If you are interested in applying for this role, please apply via our website (

The closing date for applications is 13 December 2017 at 23:30.

Please note: all offers of employment are subject to successful security screening and continuous eligibility to work in the United Kingdom.

Share this job
  Share by Email   Print this job   More sharing options
We value your feedback on the quality of our adverts. If you have a comment to make about the overall quality of this advert, or its categorisation then please send us your feedback
Advert information

Type / Role: